Search

everythinglearnresearchcommunity

for

Search:↓

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Environmental pollutants can damage hair health and cause hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Different types of PCOS need specific diagnosis methods and treatments.

Women with PCOS have different levels of certain metabolites in their blood, which could help diagnose and predict the condition.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Overweight women with PCOS are more likely to have excess male hormones.

The genetic variant studied does not affect PCOS symptoms in Kashmiri women.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

The vitamin D receptor helps regulate skin and hair health independently of its usual vitamin D ligand.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The testes produce sperm and hormones essential for male development.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.